RXi Pharmaceuticals Expands Pipeline With Additional Licensing Of Phase 2 Ready Product
December 19, 2014 at 11:56 AM EST
RXi adds Samcyprone, product for warts and advanced melanoma, to pipeline.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.